Cargando…
2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences
BACKGROUND: Adherence to antiretroviral therapy (ART) to treat HIV remains a critical global health challenge given its relationship with individual health outcomes and population-level transmission. Given barriers associated with oral ART adherence, and considerations of patients’ preferences, long...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809882/ http://dx.doi.org/10.1093/ofid/ofz360.2175 |
_version_ | 1783462106417332224 |
---|---|
author | Mantsios, Andrea R Murray, Miranda Karver, Tahilin Sanchez Davis, Wendy Margolis, David Kumar, Princy Swindells, Susan Bredeek, Fritz Deltoro, Miguel García García, Rafael Rubio Antela, Antonio Garris, Cindy Shaefer, Mark S Gomis, Santiago Cenoz Bernaldez, Miguel Pascual Kerrigan, Deanna |
author_facet | Mantsios, Andrea R Murray, Miranda Karver, Tahilin Sanchez Davis, Wendy Margolis, David Kumar, Princy Swindells, Susan Bredeek, Fritz Deltoro, Miguel García García, Rafael Rubio Antela, Antonio Garris, Cindy Shaefer, Mark S Gomis, Santiago Cenoz Bernaldez, Miguel Pascual Kerrigan, Deanna |
author_sort | Mantsios, Andrea R |
collection | PubMed |
description | BACKGROUND: Adherence to antiretroviral therapy (ART) to treat HIV remains a critical global health challenge given its relationship with individual health outcomes and population-level transmission. Given barriers associated with oral ART adherence, and considerations of patients’ preferences, long-acting injectable (LA) ART (cabotegravir + rilpivirine) is under development and has been shown to be non-inferior to daily oral ART in Phase III trials. While most of the trial participants have been men, as LA ART gets closer to becoming available for routine clinical use, it is critical to understand how this option is perceived by women. METHODS: We conducted in-depth interviews with 67 individuals, 53 people living with HIV (PLHIV) and 14 healthcare providers, in 11 sites in the United States and Spain participating in Phase III LA ART trials (ATLAS, ATLAS 2-M and FLAIR). Twenty percent (10/53) of trial participants interviewed were women. Interviews explored patient and provider perspectives and experiences with LA ART, and appropriate candidates and recommendations to support use. Interviews were audio-recorded, transcribed and coded using thematic content analysis. RESULTS: Overall, several salient themes emerged regarding participant’s generally positive experiences transitioning from daily oral ART to injectable ART including: the importance of the clinical efficacy of LA ART, the ability to learn to manage injection side-effects over time, and the “freedom” reportedly afforded by LA ART logistically and psychosocially. Women interviewed shared many of the aforementioned positive perceptions of LA ART but also had some unique perspectives. Female participants discussed how LA ART was easier to integrate into their daily lives including managing their multiple roles and responsibilities, which often involved working full-time and taking care of themselves as well as their family and children. CONCLUSION: Similar to all participants, female participants had generally positive views of LA ART. However, the gendered nature of their daily lives also led to some unique perspectives on why and how they were satisfied with LA ART that merits further exploration in future research. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6809882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68098822019-10-28 2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences Mantsios, Andrea R Murray, Miranda Karver, Tahilin Sanchez Davis, Wendy Margolis, David Kumar, Princy Swindells, Susan Bredeek, Fritz Deltoro, Miguel García García, Rafael Rubio Antela, Antonio Garris, Cindy Shaefer, Mark S Gomis, Santiago Cenoz Bernaldez, Miguel Pascual Kerrigan, Deanna Open Forum Infect Dis Abstracts BACKGROUND: Adherence to antiretroviral therapy (ART) to treat HIV remains a critical global health challenge given its relationship with individual health outcomes and population-level transmission. Given barriers associated with oral ART adherence, and considerations of patients’ preferences, long-acting injectable (LA) ART (cabotegravir + rilpivirine) is under development and has been shown to be non-inferior to daily oral ART in Phase III trials. While most of the trial participants have been men, as LA ART gets closer to becoming available for routine clinical use, it is critical to understand how this option is perceived by women. METHODS: We conducted in-depth interviews with 67 individuals, 53 people living with HIV (PLHIV) and 14 healthcare providers, in 11 sites in the United States and Spain participating in Phase III LA ART trials (ATLAS, ATLAS 2-M and FLAIR). Twenty percent (10/53) of trial participants interviewed were women. Interviews explored patient and provider perspectives and experiences with LA ART, and appropriate candidates and recommendations to support use. Interviews were audio-recorded, transcribed and coded using thematic content analysis. RESULTS: Overall, several salient themes emerged regarding participant’s generally positive experiences transitioning from daily oral ART to injectable ART including: the importance of the clinical efficacy of LA ART, the ability to learn to manage injection side-effects over time, and the “freedom” reportedly afforded by LA ART logistically and psychosocially. Women interviewed shared many of the aforementioned positive perceptions of LA ART but also had some unique perspectives. Female participants discussed how LA ART was easier to integrate into their daily lives including managing their multiple roles and responsibilities, which often involved working full-time and taking care of themselves as well as their family and children. CONCLUSION: Similar to all participants, female participants had generally positive views of LA ART. However, the gendered nature of their daily lives also led to some unique perspectives on why and how they were satisfied with LA ART that merits further exploration in future research. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809882/ http://dx.doi.org/10.1093/ofid/ofz360.2175 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Mantsios, Andrea R Murray, Miranda Karver, Tahilin Sanchez Davis, Wendy Margolis, David Kumar, Princy Swindells, Susan Bredeek, Fritz Deltoro, Miguel García García, Rafael Rubio Antela, Antonio Garris, Cindy Shaefer, Mark S Gomis, Santiago Cenoz Bernaldez, Miguel Pascual Kerrigan, Deanna 2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences |
title | 2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences |
title_full | 2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences |
title_fullStr | 2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences |
title_full_unstemmed | 2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences |
title_short | 2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences |
title_sort | 2497. women’s perspectives on and experiences with long-acting injectable anti-retroviral therapy in the united states and spain: the potential role of gender in patient preferences |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809882/ http://dx.doi.org/10.1093/ofid/ofz360.2175 |
work_keys_str_mv | AT mantsiosandrear 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT murraymiranda 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT karvertahilinsanchez 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT daviswendy 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT margolisdavid 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT kumarprincy 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT swindellssusan 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT bredeekfritz 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT deltoromiguelgarcia 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT garciarafaelrubio 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT antelaantonio 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT garriscindy 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT shaefermarks 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT gomissantiagocenoz 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT bernaldezmiguelpascual 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences AT kerrigandeanna 2497womensperspectivesonandexperienceswithlongactinginjectableantiretroviraltherapyintheunitedstatesandspainthepotentialroleofgenderinpatientpreferences |